Nexalin, Armada, Roze AI, Mattel, and Accenture lead market gains on key deals and earnings beats

On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to close on October 7. Roze AI rose 20.2% despite no new announcements, while Mattel gained 18.8% amid takeover talks and a new CEO appointment. Accenture climbed 15.8% after beating Q4 earnings and raising fiscal 2027 sales guidance. These moves highlight strong investor confidence driven by strategic partnerships, mergers, and positive financial outlooks.

Mattel shares on Pluang rose 20.06% to USD 15.20 as of Oct 02, 2026 04:22 WIB, showing strong buying interest with 100% buy orders. Accenture also gained 16.32%, trading at USD 213.29, with a balanced order flow of 52% sell and 48% buy. These figures highlight active investor engagement in these stocks following recent positive developments.